| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |